Abstract
A neonate at risk for hepatic carnitine palmitoyltransferase I (L-CPT I) deficiency was investigated from birth. The free carnitine and acylcarnitine profile in dried whole blood filter paper samples collected at ages 1 and 4 days showed a markedly elevated concentration of free carnitine (141 and 142 μmol/L, respectively), normal concentrations of acetyl- and propionylcarnitine, with the near absence of all other species. The diagnosis was confirmed by in vitro fatty acid oxidation screening assays and enzyme assay in cultured skin fibroblasts. Retrospective study of the newborn whole blood sample of the index case showed a similar profile (free carnitine 181 μmol/L). The newborn population distribution of free carnitine (n=143981) showed that only three samples had free carnitine >140 μmol/L (>99.9th centile), two were from L-CPT I-deficient neonates and one from a baby with sepsis. While there are other conditions that can cause elevated concentrations of free carnitine, an isolated elevation of free carnitine only in an apparently healthy term neonate warrants further investigation to exclude L-CPT I deficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Abadi N,Thuillier L,Prasad C, et al (1999) Molecular resolution of carnitine palmitoyltransferase I deficiency in aHutterite family. Proceedings of the 49th Annual Meet-ing of the American Society of Human Genetics San Francisco (abstract).
Bergman AJ,Donckerwolcke RA,Duran M, et al (1994) Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency. Pediatr Res 36: 582–588.
Bonnefont JP,Demaugre F,Prip-Buus C, et al (1999) Carnitine palmitoyltransferase de¢ciencies. Mol Genet Metab 68: 424–440.
Borum PR (1995) Carnitine in neonatal nutrition. J Child Neurol 10(supplement 2): S25-S31.
Bougneres PF,Saudubray JM,Marsac C,Bernard O,Odievre M,Girard J (1981) Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr 98: 742–746.
Britton CH,Schultz RA,Zhang B,Esser V,Foster DW,McGarry JD (1995) Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene. Proc Nat Acad Sci USA 92: 1984–1988.
Britton CH,Mackey DW,Esser V, et al (1997) Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT IA and CPT IB). Genomics 40: 209–211.
Brown NF,Weis BC,Husti JE,Foster DW,McGarry JD (1995) Mitochondrial carnitine palmitoyltransferase I isoform switching in the developing rat heart. J Biol Chem 270: 8952–8957.
Brown NF,Hill JK,Esser V, et al (1997) Mouse white adipocytes and 3T3-L1 cells display an anomalous pattern of carnitine palmitoyltransferase (CPT) I isoform expression during di¡erentiation. Inter-tissue and inter-species expression of CPT I and CPT II enzymes. Biochem J 327(Pt 1): 225–231.
Chace DH,Hillman SL,Millington DS,Kahler SG,Adam BW,Levy HL (1996) Rapid diag-nosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry. Clin Chem 42: 349–355.
Demaugre F,Bonnefont JP,Mitchell G, et al (1988) Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res 24: 308–311.
Gobin S,Bonnefont J-P,Prip-Buus C, et al (2000) Characterizing the organization of the “liver-type ” carnitine palmitoyltransferase 1 (L-CPT I) gene helps unravelling themolecular basis of L-CPT I deficiency in human. Proceedings of the 50th Annual Meeting of the American Society for Human Genetics, Philadelphia, Abstract 278.
Ijlst L,Mandel H,Oostheim W,Ruiter JP,Gutman A,Wanders RJ (1998) Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J Clin Invest 102: 527–531.
Innes AM,Seargeant LE,Balachandra K, et al (2000) Hepatic carnitine palmitoyltransferase I de¢ciency presenting as maternal illness in pregnancy. Pediatr Res 47: 43–45.
McGarry JD,Brown NF (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244: 1–14.
McGarry JD,Leatherman GF,Foster DW (1978) Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J Biol Chem 253: 4128–4136.
Mitchell GA,Kassovska-Bratinova S,Boukaftane Y, et al (1995) Medical aspects of ketone body metabolism. Clin Invest Med 18: 193–216.
Nada MA,Vianey-Saban C,Roe CR, et al (1996) Prenatal diagnosis of mitochondrial fatty acid oxidation defects. Prenat Diagn 16: 117–124.
Nakamura T,Sugihara H,Kinoshita N, et al (1999) Serum carnitine concentrations in patients with idiopathic hypertrophic cardiomyopathy: relationship with impaired myocardial fatty acid metabolism. Clin Sci (Colch) 97: 493–501.
Olpin SE,Manning NJ,Pollitt RJ,Clarke S (1997) Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10–3H]oleic acid. J Inherit Metab Dis 20: 415–419.
Olpin SE,Manning NJ,Pollitt RJ,Bonham JR,Downing M,Clark S (1999) The use of [9,10-3H]myristate, [9,10-3H]palmitate and [9,10-3H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. Adv Exp Med Biol 466: 321–325.
Roe CR,Roe DS (1999) Recent developments in the investigation of inherited metabolic disorders using cultured human cells. Mol Genet Metab 68: 243–257.
Schaefer J,Jackson S,Taroni F,Swift P,Turnbull DM (1997) Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy. J Neurol Neurosurg Psychiatry 62: 169–176.
Schmidt-Sommerfeld E,Werner D,Penn D (1988) Carnitine plasma concentrations in 353 metabolically healthy children. Eur J Pediatr 147: 356–360.
Shenai JP,Borum, PR,Mohan P,Donlevy SC (1983) Carnitine status at birth of newborn infants of varying gestation. Pediatr Res 17: 579–582.
Stanley CA,Sunaryo F,Hale DE,Bonnefont JP,Demaugre F,Saudubray JM (1992) Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency. J Inherit Metab Dis 15: 785–789.
Tein I,Demaugre F,Bonnefont JP,Saudubray JM (1989) Normal muscle CPT I and CPT2 activities in hepatic presentation patients with CPT I deficiency in fibroblasts. Tissue specific isoforms of CPT I? J Neurol Sci 92: 229–245.
Ventura FV,Costa CG,Struys EA, et al (1999) Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 281: 1–17.
Vianey-Saban C,Mousson B,Bertrand C, et al (1993) Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia. Eur J Pediatr 152: 334–338.
Wilcken B,Wiley V,Sim K,Carpenter K (2001) Carnitine transporter defect diagnosed by newborn screening using electrospray tandem mass spectrometry. J Pediatr (in press).
Wiley V,Carpenter K,Wilcken B (1999) Newborn screening with tandem mass spectrometry:12 months' experience in NSW Australia. Acta Paediatr Suppl 88: 48–51.
Yamazaki N,Shinohara Y,Shima A,Yamanaka Y,Terada H (1996) Isolation and characterization of cDNA and genomic clones encoding human muscle type carnitine palmitoyltransferase I. Biochim Biophys Acta 1307: 157–161
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sim, K.G., Wiley, V., Carpenter, K. et al. Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile. J Inherit Metab Dis 24, 51–59 (2001). https://doi.org/10.1023/A:1005606805951
Issue Date:
DOI: https://doi.org/10.1023/A:1005606805951